Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · VIJAYA

VIJAYA

HealthcareHealthcare Services₹15821 cr market cap
₹1510.60 ▼ -1.5% today As of 19 Nov 2026
52-week low ₹861.4052-week high ₹1570.70

-2.4% from the 52-week high · +78.0% above the low

Vijaya Diagnostic Centre Ltd. engages in the provision of diagnostic services. The company is headquartered in Hyderabad, Telangana and currently employs 1,818 full-time employees. The company went IPO on 2021-09-14. The firm is engaged in the business of providing a range of diagnostic services spanning pathological investigations, basic and high-end radiology, nuclear medicine and related healthcare services. The firm operates through the Diagnostic Services segment. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests, including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans, single photon emission computed tomography (SPECT) and advanced positron emission tomography CT (PET CT). The firm also offers a range of health and wellness packages to its customers as per their requirements. The firm has a diagnostic network with over 90 centers spread across 15 cities.

The short version. VIJAYA reported revenue of ₹255 crore for Sep 2026, up 26.2% from a year earlier. Net profit was ₹59 crore (up 37.2% year on year). Return on equity was 18.1% in Mar 2026. Promoter holding was 52.46% in Sep 2026, down 1.45 points over 8 quarters.

1 · The price

How has the stock traded?

VIJAYA trades 2.4% below its 52-week high and 78.0% above its 52-week low.

Change over period: —

1M+12.1%
3M+2.9%
6M+20.6%
1Y+49.6%

2 · The business

Is it growing?

Sales, year on year+26.2%

Sep 2026 revenue of ₹255 cr.

Profit, year on year+37.2%

Sep 2026 net profit of ₹59 cr.

Net margin23.3%

1.8 pts higher than a year earlier.

3-year growth26.9% profit

Revenue compounded at 20.8% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue255231219205202188173169
Net profit5953484343383535
Net margin %23.323.021.821.021.520.420.020.8
EPS (₹)5.775.164.664.24.213.733.373.43

Annual

FY2026FY2025FY2024FY2023FY2022
Revenue814681548459462
Net profit17314311985110
Net margin %21.221.021.718.423.7
EPS (₹)16.8113.9411.618.2910.76

3 · The quality

How well does it turn capital into profit?

Return on equity was 18.1% in Mar 2026; debt to equity is 0.00.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %18.118.018.115.5
Return on capital %19.219.820.117.1
EBITDA margin %42.841.542.141.4
Net margin %20.720.420.917.9

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR20.8%—
Profit CAGR26.9%—
Debt to equity0.00
Interest cover8.0x
Current ratio2.60
P/E ratio78.0

4 · The owners

Who holds it, and are they adding?

Promoter holding52.46%

Down 1.45 pts over 8 quarters.

Foreign institutions10.66%

Down 6.88 pts over 8 quarters.

Domestic institutions32.5%

Up 7.87 pts over 8 quarters.

Mutual fund schemes114

+32 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter53.9153.0552.6352.652.652.5152.4752.46-1.45
FII17.5419.3619.5618.2715.113.3811.6510.66-6.88
DII24.6323.7224.0725.3428.5929.9331.5832.5+7.87
Public3.923.873.743.793.714.184.314.38+0.46

Mutual fund holdings · Oct 2026

114 schemes hold this stock

82 the month before.

  • Kotak Small Cap Fund4.4% of NAV
  • Motilal Oswal Infrastructure Fund4.31% of NAV
  • Kotak Business Cycle Fund3.18% of NAV
  • SAMCO ELSS TAX SAVER FUND3.16% of NAV
  • NIPPON INDIA PHARMA FUND2.66% of NAV
  • DSP Healthcare Fund2.39% of NAV
  • MOTILAL OSWAL SMALL CAP FUND2.35% of NAV
  • Bajaj Finserv Healthcare Fund2.13% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for VIJAYA are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about VIJAYA

What is the VIJAYA share price?

VIJAYA (VIJAYA) last closed at ₹1,510.60, down 1.5% on the day. Its 52-week range is ₹861.40 to ₹1,570.70.

What is the market cap of VIJAYA?

VIJAYA has a market capitalisation of about ₹15,821 crore. Its price-to-earnings ratio is 78.0.

How are VIJAYA's latest results?

VIJAYA reported revenue of ₹255 crore for Sep 2026, up 26.2% from a year earlier. Net profit was ₹59 crore (up 37.2% year on year). Return on equity was 18.1% in Mar 2026. Promoter holding was 52.46% in Sep 2026, down 1.45 points over 8 quarters.

Who owns VIJAYA?

As of Sep 2026, shareholding was: Promoter 52.46%, FII 10.66%, DII 32.5%, Public 4.38%.

How many mutual funds hold VIJAYA?

114 mutual fund schemes held VIJAYA in October 2026. That compares with 82 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 29 Aug 2025 · Final Dividend - Rs. 2
  • 30 Aug 2024 · Final Dividend - Rs. 1
  • 13 Sep 2023 · Dividend - Rs. 1
  • 20 Sep 2022 · Final Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.